new chemical entities
Jump to
21 Results Found
  • Suven Life Sciences gets 1 product patent in India; shares up 3% Dec 07, 2016 12:25 PM IST

    Suven Life Sciences gets 1 product patent in India; shares up 3%

    With this patent, the company has a total of 20 granted patents from India.

  • Suven Life up 3%, secures 3 product patents in Europe, Eurasia Jun 29, 2016 10:54 AM IST

    Suven Life up 3%, secures 3 product patents in Europe, Eurasia

    With these new patents, the company has a total of twenty 21 granted patents from Europe and 19 granted patents from Eurasia.

  • Suven Life secures 2 product patents in Israel & Mexico; up 3% Jun 03, 2016 11:52 AM IST

    Suven Life secures 2 product patents in Israel & Mexico; up 3%

    The company has been granted one product patent from Israel and one product patent from Mexico corresponding to the new chemical entities for the treatment of disorders associated with Neurodegenerative diseases.

  • Suven Life gets patents for neuro-degenerative drug May 23, 2016 12:56 PM IST

    Suven Life gets patents for neuro-degenerative drug

    In a regulatory filing today, Suven Life said it has "secured product patents in Australia, Eurasia, Israel and the US to their New Chemical Entities (NCEs) for CNS therapy through mechanism of action".

  • Suven Life Sciences secures 4 product patents; stock gains 3% May 23, 2016 11:17 AM IST

    Suven Life Sciences secures 4 product patents; stock gains 3%

    The company has secured product patents in Australia, Eurasia, Israel and USA to their NCE‘s for CNS therapy through mechanism of action – H3 Inverse agonist and these patents are valid until 2032, 2030, 2031 and 2032 respectively.

  • Suven Life secures 4 product patents, stock gains 5% Dec 11, 2015 12:29 PM IST

    Suven Life secures 4 product patents, stock gains 5%

    These patents are corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases and are valid through 2030.

  • Suven Life gains 6%, gets 5 patents for their NCE‘s Oct 13, 2015 10:51 AM IST

    Suven Life gains 6%, gets 5 patents for their NCE‘s

    It has received these patents in Australia, China, Europe, South Korea and USA for CNS therapy through mechanism of action – H3 Inverse agonist and these patents are valid until 2031, 2030,2031, 2030 and 2031 respectively.

  • Suven Life Sciences rises 7%, secures 5 product patents Sep 10, 2015 11:38 AM IST

    Suven Life Sciences rises 7%, secures 5 product patents

    With these new patents, Suven has total of 17 granted patents from China, 7 from Israel, 20 from Mexico, 21 from Singapore and 11 from Sri Lanka.

  • Suven Life gets patents in China, Mexico, SA; gains 6.5% Jul 13, 2015 11:01 AM IST

    Suven Life gets patents in China, Mexico, SA; gains 6.5%

    The company has got patents in China and South Africa to their NCE‘s for CNS therapy through mechanism of action – H3 Inverse agonist and these patents are valid until 2031,2030 and 2031 respectively.

  • Suven Life Sciences gets patents for neurodegenerative drug Jun 16, 2015 12:00 PM IST

    Suven Life Sciences gets patents for neurodegenerative drug

    Biopharmaceutical firm Suven Life Sciences on Tuesday said it has been granted one patent each by the US, Israel and Macau for a drug used in the treatment of neurodegenerative diseases.

  • Suven Life up 7%; bags 2 product patents in Europe & HK May 13, 2015 11:21 AM IST

    Suven Life up 7%; bags 2 product patents in Europe & HK

    The company has bagged one product patent from Europe and one product patent from Hong Kong.

  • Suven gets patents for neuro-degenerative disorder drug Apr 24, 2015 01:00 PM IST

    Suven gets patents for neuro-degenerative disorder drug

    With these new patents, Suven has a total of 21 granted patents from Australia, 15 from Europe, 16 from Hong Kong, four from Israel and five from Norway. These granted patents are exclusive intellectual property of Suven and are achieved through the internal discovery research efforts.

  • Suven Life Sciences gets patent for neuro-degenerative drug Mar 09, 2015 12:32 PM IST

    Suven Life Sciences gets patent for neuro-degenerative drug

    Pharmaceutical firm Suven Life Sciences has been granted a patent each by Eurasia and Israel for drug used in the treatment of neuro-degenerative diseases.

  • Suven Life soars 7%, gets 5 product patents in 4 countries Dec 12, 2014 11:34 AM IST

    Suven Life soars 7%, gets 5 product patents in 4 countries

    Suven today received the two product patents from Israel, one product patent each from Japan, China and New Zealand corresponding to the new chemical entities (NCEs) for the treatment of disorders associated with neurodegenerative diseases.

  • Suven Life at new high, up 5%; gets patents in 3 countries Sep 03, 2014 11:40 AM IST

    Suven Life at new high, up 5%; gets patents in 3 countries

    With these new patents, Suven has a total of 14 granted patents from South Korea, 14 granted patents from China and 16 product patents from Canada.

  • Suven Life Sciences up 8.5% on getting 3 patents for NCEs Jan 09, 2014 03:48 PM IST

    Suven Life Sciences up 8.5% on getting 3 patents for NCEs

    These patents, which are valid through 2029, are related to new chemical entities for the treatment of disorders associated with Neurodegenerative diseases.

  • Suven Life Sciences gains 3%, gets 3 product patents Sep 25, 2013 11:49 AM IST

    Suven Life Sciences gains 3%, gets 3 product patents

    With these three patents, Suven has a total of 17 granted patents from New Zealand, 16 granted patents from Singapore and 11 granted patents from South Korea.

  • Suven at 2-year high on 5 product patents in China, Korea Dec 13, 2012 12:34 PM IST

    Suven at 2-year high on 5 product patents in China, Korea

    Healthcare firm Suven Life Sciences has touched a two-year high of Rs 35.25 on Thursday as the company has secured 5 product patents for their new chemical entities (NCEs) in China and Korea.

  • Dr Reddy's expands operations in UK Oct 08, 2012 10:25 PM IST

    Dr Reddy's expands operations in UK

    Pharma major Dr Reddy's Laboratories (DRL) today said it has expanded its manufacturing operations in the United Kingdom.

  • Suven Life gets four patents for new chemical entities Aug 18, 2011 11:34 AM IST

    Suven Life gets four patents for new chemical entities

    Suven Life Sciences has received four product patents for their new chemical entities (NCE) for treatment of disorders associated with neurodegenerative disorders like Alzheimer’s, Attention Deficit Hyperactivity Disorder (ADHD), Huntington’s disease, Parkinson and Schizophrenia.

  • Suven gets four patent approvals for CNS molecules May 26, 2011 01:53 PM IST

    Suven gets four patent approvals for CNS molecules

    Suven Life sciences on Thursday said it has received four product patents from different countries for its new chemical entities (NCEs) which could be used in treating various central nervous system disorders.

Sections